Sponsor Pipeline

Dong sheng Zhang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07397819 Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With… Malignant Ascites Recruiting
Get alerts when Dong sheng Zhang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free